Prediction of clinical response after 1 year of infliximab therapy in rheumatoid arthritis based on disease activity at 3 months: Posthoc analysis of the RISING study
- Tsutomu Takeuchi
- , Nobuyuki Miyasaka
- , Takashi Inui
- , Toshiro Yano
- , Toru Yoshinari
- , Tohru Abe
- , Takao Koike
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Citations
(Scopus)